- Product NDC
- 0813-0202
- 11-digit product format
- 008130202
- Labeler code
- 0813
- Product ID
- 0813-0202_9e230010-696b-42ff-af18-768dce0b5c87
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Vitamin A, Ascorbic Acid, Cholecalciferol, .ALPHA.-TOCOPHEROL ACETATE, THIAMINE MONONITRATE, Riboflavin, Niacin, Pyridoxine, Folic Acid, Cyanocobalamin, Calcium, FERROUS FUMARATE, Iodine, Magnesium, Zinc, and Copper
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Pharmics, Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2002-01-23
- Marketing end
- 0000-00-00
- Substance
- VITAMIN A; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE; THIAMINE MONONITRATE; RIBOFLAVIN; NIACIN; PYRIDOXINE; FOLIC ACID; CYANOCOBALAMIN; CALCIUM; FERROUS FUMARATE; IODINE; MAGNESIUM; ZINC; COPPER
- Active strength
- 2500 [iU]/1; mg/1; [iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1
- Pharmacologic classes
- Vitamin A [CS],Vitamin A [EPC],Vitamin C [EPC],Ascorbic Acid [CS],Vitamin D [CS],Vitamin D [EPC],Nicotinic Acid [EPC],Nicotinic Acids [CS],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Calcium [CS],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Copper [CS],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record